New York, NY: McGraw-Hill;2014
Introduction# GHRP-6 and Ipamorelin are both synthetic growth hormone secretagogues that stimulate pituitary GH release through the ghrelin receptor (GHS-R1a), but they sit at opposite ends of the selectivity spectrum
doi: 10.1007/s11102-009-0213-z 179 MantleDHargreavesIP
(McElroy has previously consulted for Eli Lilly, Novo Nordisk, and other companies.) One case, published in 2025, involved a woman who had been treated for anorexia as a child and was later prescribed tirzepatide for diabetes, hypertension, and liver issues
Some people should not take BPC-157, including: Pregnant or breastfeeding women People with kidney disease Those with heart conditions Diabetics or obese individuals Those taking certain medications should speak with a doctor before using BPC-157
Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants